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Abstract 
Most clinical mastitis (CM) cases are treated in the same way, following a farm-specific 
treatment protocol. Cure rates, however, are strongly influenced by several cow factors. 
Therefore each CM case should be treated in the most appropriate way, based on those 
specific cow factors. The objective of this research was to develop a simulation model to 
determine the most proper treatment for each CM case in terms of total costs. Total costs of 4 
different antibiotic treatment regimes (standard intramammary, extended intramammary, 
combination intramammary + parenterally, and combination extended intramammary + 
parenterally) were compared by simulating 5,000 CM cases. All input for the model was 
based on literature information and authors’ knowledge. Bacteriological cure for each 
individual cow depended on the choice of treatment, the causal pathogen and the cow factors 
parity, SCC and CM history. Total costs for each individual case were dependent on treatment 
costs, milk production losses and costs for culling. Mean total costs for the 4 treatments were 
€170, €189, €190 and €209, respectively. For 65% of CM cases the 3-day intramammary 
antibiotic treatment had the lowest costs and was defined as optimal. For 23% of the cases an 
extended intramammary treatment was optimal, while for 10% and 1% of the cases the 
combination intramammary + parenterally and the combination extended intramammary + 
parenterally were optimal, respectively. For 1% of the CM cases, immediate culling was 
optimal. For cows producing more than 35 kg, for cows which had previous CM cases and for 
cows in the first months of lactation, the more intensive antibiotic treatments became more 
advantageous. The results show the potential of a cow-specific treatment of CM. 
 
 
Introduction 
Most clinical mastitis (CM) cases are treated in the same way, following a farm-specific 
treatment protocol. It is, however, known that the cure rate of CM is highly cow dependent 
(Bradley and Green, 2009). By taking into account cow factors, it is possible to choose the 
most proper treatment. For instance, it is likely that a heifer with a low SCC and no CM 
history will cure by using a standard antibiotic treatment, while an older cow with a high SCC 
and a history of CM might need an extended antibiotic treatment to cure.  
Choosing the proper treatment for each CM case, which also includes the option to cull a cow 
with CM immediately (Bar et al., 2008b), can result in more prudent use of antibiotics. The 
most proper treatment of CM is often measured in terms of clinical or bacteriological cure. 
Dairy farming is, however, an economic enterprise, and it could be argued that the real 
measure of cure should be the cost-benefit of treatment (Barkema et al., 2006).  
In the current study, a stochastic Monte Carlo model was developed to simulate CM cases 
treated with one of four different antibiotic treatment regimes, or immediately culled. 
Subsequently, this model was used to determine for which cows which option for CM is 
optimal in terms of total costs.  
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Material and Methods 
Model development 
The model described in this paper was built using Microsoft Excel with @Risk add-in 
software (Palisade, 2002). All discrete events and variability at the cow level were triggered 
stochastically, using random numbers drawn from distributions. Input for these distributions 
was based on knowledge of the model domain, information from literature and expertise of 
the authors.  
Model outcomes were generated in 3 steps. First, every iteration (5,000 in total) during the 
simulation process gave a specific cow with CM caused by streptococci, Staphylococcus 
aureus or Escherichia coli. In the second step the follow-up of this CM case for each of the 
five treatments (4 different antibiotic treatment regimes and immediate culling) were 
simulated. The third step involved calculation of the associated costs for each of the five 
treatments for this case. Finally, for each simulated CM case, the most proper treatment was 
defined as the option with the lowest total costs.   
 
Simulation of CM cases 
By using a discrete probability distribution, for each CM case the causal pathogen was 
simulated (streptococci (40%), S. aureus (30%) or E. coli (30%)). Subsequently, for each cow 
with CM, the parity, the day in milk, the most recent SCC (adapted after Steeneveld et al., 
2009), the 305-day milk production, the calving interval and whether it was a repeated CM 
case or not (Döpfer et al., 1999; Swinkels et al., 2005a; Swinkels et al., 2005b) were 
determined. Daily milk production at day of CM and the remaining milk production during 
the rest of lactation were estimated by Wood’s lactation curve (Wood, 1967).  
 
Simulation of effect of treatment of a CM case 
Four different antibiotic treatment regimes were defined, differing in route of application, 
duration, costs, treatment time, days of milk withdrawal and bacteriological cure rate (Table 
1).  
For each CM case, treated with the four defined antibiotic treatment regimes, it was 
determined whether it was cured bacteriologically or not. If the cow was not cured 
bacteriologically, the cow had a probability to be clinically cured. All non-clinically cured 
CM cases were treated again with the same antibiotic treatment.  If after retreatment no 
clinical cure had occurred, the cow had a 5% chance of dying and a 95% probability that the 
infected quarter would be dried-off. Cows with dried-off quarters had a probability of being 
culled during the remainder of the lactation of 33%. All completely cured CM cases had a 
probability varying between 5 and 25%, depending on the number of CM cases, of being 
culled during the remainder of the lactation. All non-bacteriologically cured CM cases had a 
probability of having a clinical flare-up later in lactation of 10%, 12% and 5% for 
streptococci, S. aureus and E. coli, respectively (Döpfer et al., 1999; Swinkels et al., 2005a; 
Swinkels et al., 2005b). Additionally, cows not cured bacteriologically had a probability of 
being culled during the remainder of lactation. This probability was 16% for cows with 1 
previous CM case and 20% for cows with 2 previous CM cases. If treatment of the second 
clinical flare-up did not result in bacteriological cure, the cow was culled immediately (Table 
2 + Figure 1).  
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Table 1. Characteristics of the four defined antibiotic treatment regimes.  
 Antibiotic treatment regime 
 IMM1 IMM2 IMM_P1 IMM_P2 
Application 
(number) 
Intramammary 
(3) 
Intramammary 
(5) 
Intramammary (3) 
+ parenterally (3) 
Intramammary (5) 
+ parenterally (3) 
Total costs  
antibiotics (€) 15 25 45 55 
# days milk 
withdrawal 5 7 5 7 
Total treatment time 
(minutes) 42 62 45 65 
Bacteriological cure 
(%)1,2 
    Streptococci 
    S. aureus 
    E. coli 
 
 
75 
40 
80 
 
 
80 
50 
85 
 
 
80 
60 
85 
 
 
85 
70 
90 
Clinical cure (%) for 
non-bacteriological 
cured CM cases  
    Streptococci 
    S. aureus 
    E. coli 
 
 
 
60 
60 
40 
 
 
 
60 
60 
40 
 
 
 
60 
60 
40 
 
 
 
60 
60 
40 
1Bacteriological cure rates assumed for heifers, with somatic cell count <200,000 cells/mL 
and no clinical mastitis before. 
2For multiparous cows a 10% lower cure rate was assumed, for SCC 200-500 a 10% lower 
cure rate was assumed, for SCC >500 a 15% lower cure rate was assumed, for a repeated CM 
cases the cure rate was divided by 2.  
 
Bacteriological cure rates from literature were used (Bradley and Green, 2009; McDougall et 
al., 1998; McDougall et al., 2003; McDougall et al., 2007; Sol et al., 2000) as basis for the 
success rate of the four defined antibiotic regimes. Based on those cure rates, the maximum 
bacteriological cure for CM cases caused by streptococci, S. aureus and E. coli was 
determined based on expertise of the authors for all four regimes. The maximum cure was 
assumed for heifers with a SCC below 200,000 cells/mL and no CM case before (Table 1). 
Thereafter, that maximum bacteriological cure rate was adapted, based on the literature 
(Barkema et al., 2006; Bradley and Green, 2009) and expertise of the authors, for the parity of 
the cow, the most recent SCC and whether it was a repeated case or not. In comparison with 
the maximum, for CM cases in older cows the cure rate was reduced by 10%, for CM cases 
after a SCC between 200,000 and 500,000 cells/mL the cure rate was reduced by 10%, for 
CM cases after a SCC above 500,000 cells/mL the cure rate was reduced by 15% and for 
repeated CM cases the cure rate was divided by two.  
 
Costs of CM 
The costs for CM included costs for antibiotics (Table 1), costs for discarded milk (€0.17 per 
kg), labour (hourly rate of €18), costs for milk production losses (€0.12 per kg) and costs for 
culling. 
The costs for each culled cow were expressed using the retention pay-off (RPO) value of a 
cow. The RPO is defined as the maximum amount of money that should be spent to keep a 
cow in case of health problems. The RPO was calculated with a stochastic model developed 
by Houben et al. (1994). 
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The effect of CM on the degree of milk losses varies, depending on the causal pathogen 
(Schukken et al., 2009), the parity, time after CM case (Bar et al., 2007) and whether the cow 
was cured bacteriologically or not. For bacteriologically cured streptococci in heifers milk 
production losses varied between 6% (month 1) and 1% (month 8). For bacteriologically 
cured S. aureus and E. coli in heifers, 2% and 4% more production losses were assumed for 
each month after treatment of CM, respectively. For older cows, 5% more production losses 
were added. For non-bacteriologically cured CM cases 5% more production losses were 
added. Cows with dried-off quarters had in total 15% milk production losses in the remaining 
of lactation. By using the percentages, the total milk production losses for the remaining 
lactation were calculated based on Wood’s lactation curve.  
 
Table 2. Values and source of value of parameters used in the simulation model for antibiotic 
treatment of a clinical mastitis (CM) case.  
Parameter Value Source 
Probability of clinical flare-up for non-  
bacteriological cured CM cases 
      Streptococci 
      S. aureus 
      E. coli 
 
 
10% 
12% 
5% 
 
 
Swinkels et al., 2005b 
Swinkels et al., 2005a 
Döpfer et al., 1999 
Probability of being culled for non-
bacteriological cured CM cases 
      1 previous CM case 
      2 previous CM cases 
 
 
16% 
20% 
 
 
Adapted after Bar et al., 
2008a  
Probability of being culled for  
      completely cured CM cases 
5-25%1 Adapted after Bar et al., 
2008a 
Probability of dying for non-clinical 
      cured retreated CM cases 
5% Adapted after Bar et al., 
2008a 
Probability of drying-off quarter for  
      non-clinical cured retreated CM cases 
95% Expertise 
 
1Dependent on the number of previous CM cases.  
106
Nantes, 14-15 January 2010: Farm Animal Health Economics 
Treated CM
Bact. + clin. 
cure
Bact. + clin. 
cure
Bact. + clin. 
cure
Dry-off 
quarter 
Treatment of
clin. flare-up
No bact. cure,
no clin. cure
No bact. cure,
no clin. cure
No bact. cure,
no clin. cure
No bact. cure,
no clin. cure
Bact. + clin. 
cure
No bact. cure,
clin. cure
No bact. cure,
clin. cure
No bact. cure,
clin. cure
No bact. cure,
clin. cure
Treatment of
clin. flare-up
No bact. cure,
no clin. cure
Bact. + clin. 
cure
No bact. cure,
clin. cure
End 
lactation
Dying
End 
lactation
Culling   
Culling   
Culling   
Culling   
Culling   
Culling   
Culling   
Extended 
treatment 
Extended 
treatment 
End 
lactation   
End 
lactation
End 
lactation
Culling   
End 
lactation
End 
lactation
End 
lactation Culling   Culling   
Dry-off 
quarter Dying
Culling   End lactation
 
Figure. 1. Schematic representation of the simulation model for treatment of a clinical 
mastitis (CM) case. (bact. = bacteriological, clin.= clinical).  
 
Results 
The mean total costs of the four treatment regimes varied between €170 and €209, the mean 
costs for immediate culling was €599. The costs for milk production losses and culling 
decreased with the more intensive treatments (Table 3). The mean bacteriological cure rates 
of the four treatments were 51%, 59%, 64% and 73%, respectively.  
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Table 3. Mean total costs (€) for the four antibiotic treatment regimes and for immediately 
culling. Also costs for the different cost factors (5% and 95% percentiles given between 
brackets).  
 Antibiotic treatment regime 
 IMM1 IMM2 IMM_P1 IMM_P2 Culling 
Antibiotics 17 
(15; 30) 
28 
(25; 50) 
50 
(45; 90) 
60 
(55; 110) 
- 
Milk withdrawal 27 
(9; 55) 
37 
(12; 73) 
27 
(9; 52) 
37 
(12; 61) 
- 
Labour 15 
(13; 25) 
21 
(19; 37) 
15 
(14; 27) 
21 
(20; 39) 
- 
Milk production 
losses 
71 
(19; 147) 
68 
(19; 143) 
66 
(19; 136) 
63 
(18; 126) 
- 
Culling 40 
(0; 383) 
35 
(0; 381) 
32 
(0; 365) 
28 
(0; 350) 
599 
(176; 1020) 
Total costs 170 
(61; 535) 
189 
(80; 543) 
190 
(90; 532) 
209 
(110; 530) 
599 
(176; 1020) 
 
The input variables on costs of culling, probability of culling and amount of milk production 
losses had an effect on the total mean costs of the four defined antibiotic treatment regimes 
for CM (Table 4).  
 
Table 4. The effect of different input variables on the mean total costs (€) for the four 
antibiotic treatment regimes. 
 Antibiotic treatment regime 
 IMM1 IMM2 IMM_P1 IMM_P2 
Default 170 189 190 209 
Costs culling  
    + €100 
    - €100 
 
182 
158 
 
197 
184 
 
199 
182 
 
220 
203 
Probability culling  
    + 5% 
    - 5% 
 
188 
153 
 
207 
171 
 
211 
172 
 
231 
193 
Milk production 
losses  
    + 5% 
    - 5% 
 
 
197 
142 
 
 
221 
165 
 
 
221 
160 
 
 
238 
180 
 
In total, for 65% of all 5,000 simulated CM cases the 3-day intramammary antibiotic 
treatment had the lowest costs and was defined optimal. For 23% of the cases an extended 
intramammary treatment was optimal, while for 10% and 1% of the cases the combination 
intramammary + parenterally and the combination extended intramammary + parenterally 
were optimal, respectively. For 1% of the cases immediate culling was optimal (Table 5). By 
looking to specific cow characteristics, the more intensive antibiotic treatments became more 
advantageous, for instance, for cows producing more than 35 kg, for cows with a repeated 
CM case and for cows in the first three months of lactation (Table 5).   
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Discussion 
The costs of CM and, therefore, the choice of optimal treatment regime are highly influenced 
by the costs for milk production losses and costs of culling (Table 3). In the current study, 
probabilities of culling were included in the model. Culling, however, is a complex 
phenomenon, and the probability of cows being culled is farm dependent. To include culling 
in a more realistic way, farm-specific culling rules can be included or culling decisions can be 
optimized (Bar et al., 2008b).  
 
Table 5. Effect of cow factors on the optimal treatment option for clinical mastitis. 
 Optimal option (%) 
 IMM1 IMM2 IMM_P1 IMM_P2 Culling 
Default 65 23 10 1 1 
Causal pathogen 
    Streptococci 
    S. aureus 
    E. coli 
 
72 
52 
75 
 
20 
26 
20 
 
6 
16 
5 
 
1 
4 
0 
 
1 
2 
0 
Daily milk production (kg) 
    <20 
    20-25 
    25-30 
    30-35 
    35-40 
    >40 
 
74 
77 
75 
70 
63 
56 
 
19 
13 
17 
17 
26 
27 
 
4 
7 
6 
8 
10 
14 
 
1 
0 
0 
1 
1 
3 
 
2 
3 
2 
4 
0 
0 
Clinical mastitis history 
     No 
     Yes 
 
66 
58 
 
22 
26 
 
9 
12 
 
2 
3 
 
1 
1 
Month in lactation 
     1 
     2 
     3 
     4 
     5 
     6 
     7 
     8 
 
55 
57 
58 
74 
79 
77 
79 
74 
 
26 
28 
28 
19 
14 
13 
12 
21 
 
14 
12 
12 
5 
5 
7 
7 
3 
 
3 
2 
2 
1 
0 
1 
1 
1 
 
2 
1 
0 
1 
2 
2 
1 
1 
 
For the current study, information on cure rates for four different antibiotic treatments was 
needed for cows with different parity, SCC history and CM history. Results of several clinical 
trials on effectiveness of antibiotic treatments were reported (e.g., Sol et al., 2000; McDougall 
et al., 2007; Bradley and Green, 2009), but such detailed information on cure rates was not 
available. Therefore, in the current study expertise of the authors was used to estimate the 
cure rates. The cure rates had a large influence on the optimal treatment. Because such 
detailed information on cure rates is not available, for further study it will be good to use 
more expert knowledge on cure rates.  
In conclusion, the results of the current study show the potential for cow-specific treatment of 
CM. On average, for 35% of the CM cases the standard 3-day intramammary antibiotic 
treatment did not have the lowest costs. By taking into account specific cow information, it 
was possible to determine for which cows with CM the more intensive antibiotic treatment 
regimes were advantageous.  
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